+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Geriatric Medicine Market 2020-2026

  • PDF Icon


  • October 2020
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 5240814
North America Geriatric Medicine Market Size, Share & Trends Analysis Report by Therapeutic (Analgesic, Anticoagulant, Antihypertensive, Antidiabetic, and Others) and by Condition (Cardiovascular Diseases (CVDs), Diabetes, Neurological, Cancer, Respiratory, and Others) and Forecast 2020-2026.

The North American geriatric medicine market is projected to witness a CAGR of 4.9% during the forecast period. The major factors contributing to the growth of the market include the increasing geriatric population and rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs) and cancer. With the rising elderly care health centers in the region, the demand for geriatric-specific medicines will further augment during the forecast period.

The geriatric medicine market is classified on the basis of therapeutics and conditions. Based on therapeutics, the market is segmented into analgesic, anticoagulant, antihypertensive, antidiabetic, and others. Based on the condition, the market is segregated into CVDs, diabetes, neurological, cancer, respiratory, and others. Among these conditions, the CVDs segment contributes significantly to the market. The prominent share of the segment is backed by the significant patient pool of CVDs across the globe. With the rise in age, the development of CVDs increases subsequently. Therefore, a huge market is covered by CVDs medicines in the geriatric medicine market.

North America's geriatric medicine market is segmented on the basis of countries, the US, and Canada. The US held the largest market value in the North American geriatric medicine market due to ongoing research activities related to different types of geriatric medicine to improve elderly care. Furthermore, the country has the presence of some of the leading market players, such as Abbott Laboratories Inc. and Eli Lilly and Co., which contributes to the significant growth in the demand for geriatric medicine in the US.

The North American geriatric medicine market is influenced by product development and advancements conducted by the market players. Some of the key players of the geriatric medicine market include Pfizer Inc., Bristol-Myers Squibb Co., Abbott Laboratories, Johnson & Johnson Services Inc., Eli Lilly and Co., Boehringer Ingelheim GmbH, and AstraZeneca PLC. These players are playing a significant role in the growth of the geriatric medicine market by providing various products and adopting several strategies such as merger and acquisition, partnerships and collaboration, technological development, and others.

Research Methodology

The market study of the North American geriatric medicine market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog
The report is intended for drug manufacturers, pharmaceutical & biopharmaceutical companies, research institutes, academic institutes, industry associates & experts, government organizations, regulatory bodies, and other market participants for overall market analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. North America Geriatric Medicine Market Research and Analysis by Therapeutics
2. North America Geriatric Medicine Market Research and Analysis by Condition

The Report Covers:
  • Comprehensive research methodology of the North American geriatric medicine market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American geriatric medicine market.
  • Insights about market determinants which are stimulating the North American market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Pfizer Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.1.2. Bristol-Myers Squibb Co. Overview Financial Analysis SWOT Analysis Recent Developments
3.1.3. Abbott Laboratories Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.1.4. Eli Lilly and Co. Overview Financial Analysis SWOT Analysis Recent Developments
3.1.5. Boehringer Ingelheim GmbH Overview Financial Analysis SWOT Analysis Recent Developments
3.2. Key Strategy Analysis
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. North American Geriatric Medicine Market by Therapeutic
5.1.1. Analgesic
5.1.2. Anticoagulant
5.1.3. Antihypertensive
5.1.4. Antidiabetic
5.1.5. Others (Statins and Antipsychotic)
5.2. North American Geriatric Medicine Market by Condition
5.2.1. Cardiovascular Diseases (CVDs)
5.2.2. Diabetes
5.2.3. Neurological
5.2.4. Cancer
5.2.5. Respiratory
5.2.6. Others (Arthritis and Osteoporosis)
6. Regional Analysis
6.1. United States
6.2. Canada
7. Company Profiles
7.1. Abbott Laboratories Inc.
7.2. Amgen Inc.
7.3. Astellas Pharma Inc.
7.4. AstraZeneca PLC
7.5. Boehringer Ingelheim GmbH
7.6. Bristol-Myers Squibb Co.
7.7. Cipla Ltd.
7.8. Eli Lilly and Co.
7.9. GlaxoSmithKline PLC
7.10. Johnson & Johnson Services Inc.
7.11. Merck & Co., Inc.
7.12. Novartis AG
7.13. Pfizer Inc.
7.14. Sanofi SA
7.15. Teva Pharmaceutical Industries Ltd.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Co.
  • Cipla Ltd.
  • Eli Lilly and Co.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.